Sanofi iAwards Europe

What is it?

A booster to transform groundbreaking ideas in the field of target identification, disease knowledge and translational science into innovative therapeutic solutions. We partner with best-in-class academics to serve a common goal: accelerating innovation for patients.

About the program

  • A seed funding of 120 000 euros. 
  • A dedicated support of a Sanofi scientific expert.
  • A steppingstone to further collaboration.

Who are we looking for?

Principal investigators from academic partner institutions developing cutting-edge therapeutic solutions in the following areas: 

  • Oncology
  • Immunology and inflammatory diseases 
  • Rare and Neurological diseases 
  • Cell and gene therapies 
  • Vaccines 

Ongoing call for projects

Submission deadline June 2nd, 2023

Only principal investigators belonging to one of the iAwards partner institutions are eligible to this call. For more information, please contact EMEA_iAwards-Europe@sanofi.com.

Our selection process

A fast process to select and start projects in less than 8 months

Week 0

Call launch

2022 iAwards Recipients

ADJALI Oumeya

Inserm

AL JAMAL Khuloud

King’s College London

BAEZA-GARCIA Alvaro

Inserm

BOCKELMANN Ulrich

Inserm

CHAIGNE Benjamin

AP-HP

CORGNAC Stephanie

Gustave Roussy

EDBAUER Dieter

Ludwig Maximilian University of Munich

FILLATREAU Simon

Inserm

GERST Jeffrey

The Weizmann Institute

GLOWACKI François

Inserm

MAGNON Claire

Inserm

SAUZEAU Vincent

Inserm

SHACHAR Idit

The Weizmann Institute

SKIDMORE John

University of Cambridge

ULITSKY Igor

The Weizmann Institute

VLLASALIU Driton

King’s College London

WOSZCZEK Grzegorz

King’s College London

iAward Program Partners

France

Assistance Publique – Hôpitaux de Paris

AP-HP

Centre Léon Bérard

CLB

Centre International de Recherche en Infectiologie

CIRI

Gustave Roussy

INSERM

Institut National de la Santé Et de la Recherche Médicale

Institut Curie

Institut de la Vision

Institut Imagine

Institut Pasteur

Israel

Weizmann Institute

Spain

Spanish National Cancer Research Centre

CNIO

Germany

Berlin Institute of Health at La Charité

BIH-Charité

German Cancer Research Center

DKFZ

Ludwig Maximilians Universität München

LMU

Max Delbrück Center

MDC

Translational Oncology

TrOn

United Kingdom

Cambridge University

King’s College London

Holland

The Netherlands Cancer Institute

Switzerland

Université de Genève

For more information